Trials / Completed
CompletedNCT02049606
To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients of the Knee
Double Blinded, Randomized, Active Drug Comparative, Multi-center, Phase Ⅳ Clinical Study to Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients of the Knee.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 134 (actual)
- Sponsor
- PMG Pharm Co., Ltd · Industry
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double-blind study to compare the efficacy and safety of LAYLA tablet and CENATONE tablet in the treatment of osteoarthritis of the knee.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LAYLA tablet | 1 Tablet twice a day |
| DRUG | CENATONE tablet | 2 Tablets once a day |
Timeline
- Start date
- 2014-02-24
- Primary completion
- 2015-05-11
- Completion
- 2016-05-30
- First posted
- 2014-01-30
- Last updated
- 2017-09-20
Locations
6 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02049606. Inclusion in this directory is not an endorsement.